Individualized cancer therapy

作者: David M. Shanahan , Donald Rao , Phillip B. Maples , Neil Senzer , I John J. Nemunaitis

DOI:

关键词: RNAMolecular biologyCancer therapyGeneCancer researchBiologyGene chip analysisRNA interferenceDelivery vehicleExpression cassetteCancer

摘要: In certain preferred embodiments, the invention provides methods for treating cancer, which comprise (a) obtaining a specimen of cancer tissue from patient; (b) normal in proximity such (c) extracting total protein and RNA tissue; (d) expression profile using 2D DIGE mass spectrometry; (e) identifying proteins that are expressed at significantly different levels than (f) gene microarray technology comparing results thereof to profile; (g) prioritizing over-expressed by assessing connectivity other cancer-related or stimulatory proteins; (h) designing an appropriate interference cassette to, directly indirectly, modulate genes encoding prioritized (i) incorporating said into delivery vehicle; (j) providing patient with effective amount vehicle modify (i.e., production) proteins.

参考文章(187)
T. Suzuma, S. Oura, J. Arimoto, Robert M. Hoffman, I. Hirai, T. Furukawa, T. Bessho, T. Yoshimasu, T. Kubota, Y. Naito, T. Sakurai, H. Tanino, Acquisition of multidrug resistance in recurrent breast cancer demonstrated by the histoculture drug response assay. Anticancer Research. ,vol. 21, pp. 4083- 4086 ,(2001)
Wayne Christopherson, Roberta B. Ness, Heather Eng, Stephin R. Wisniewski, Cell viability assay for drug testing in ovarian cancer: in vitro kill versus clinical response. Anticancer Research. ,vol. 22, pp. 1145- 1149 ,(2002)
Robert D. Simari, Zhi-Yong Yang, Xu Ling, Dominique Stephan, Neil D. Perkins, Gary J. Nabel, Elizabeth G. Nabel, Requirements for enhanced transgene expression by untranslated sequences from the human cytomegalovirus immediate-early gene. Molecular Medicine. ,vol. 4, pp. 700- 706 ,(1998) , 10.1007/BF03401764
M. L. van Slooten, G. Storm, A. Zoephel, Z. Küpcü, O. Boerman, D. J. A. Crommelin, E. Wagner, R. Kircheis, Liposomes Containing Interferon-Gamma as Adjuvant in Tumor Cell Vaccines Pharmaceutical Research. ,vol. 17, pp. 42- 48 ,(2000) , 10.1023/A:1007514424253
Hideo Morioka, Hiroo Yabe, Takeshi Morii, Satoko Yuasa, Rikuo Yamada, Shiyoujirou Kato, Takashi Yano, In vitro chemosensitivity of human soft tissue sarcoma. Anticancer Research. ,vol. 21, pp. 4147- 4151 ,(2001)
Vipul Periwal, Jeffrey Fox, Colin Hill, Scale-free network inference methods ,(2002)
SK Tate, DB Goldstein, SM Sisodiya, Pharmacogenetics goes genomic (vol 4, pg 937, 2003) Nature Reviews Genetics. ,(2004)
Baoling Ying, Ann Tollesfson, William Wold, Adenovirus replication-competent vectors expressing trail ,(2004)
Donald Rao, Neil Senzer, John J. Nemunaitis, Bi-functional shRNA targeting Stathmin 1 and uses thereof ,(2012)